Google and microbiome company AMILI are launching AMILI Optimise, a nutrition app that replaces calorie counting with personalized recommendations based on gut microbiome data and measured blood glucose response, reflecting a broader industry shift toward biology-driven diet apps.
Germany's nationwide PRAIM program found AI-supported mammography screening lifted breast cancer detection to 6.7 per 1,000 women screened, a statistically superior 17.6% jump over standard reading, in one of the largest real-world AI screening deployments to date.
Medtronic won FDA clearance for a smart MDI system that merges its InPen insulin pen with Abbott's Instinct CGM sensors into one real-time dashboard, part of a broader 2026 push to ease the daily burden of diabetes management.
Oura launched a proprietary AI model built specifically for women's health, then expanded it in May 2026 with new hormonal birth control and menopause insight features, part of a broader wave of femtech companies building AI tools for a historically underserved area of medicine.
Epic has launched real-time prior authorization checks at Ochsner Health, Froedtert ThedaCare, Denver Health, and Summit Health, letting clinicians instantly see insurer requirements inside the EHR, months ahead of a January 2027 federal deadline.
The 2026 State of Nursing Survey finds only 22% of nurses trust AI tools for patient care and 60% say they were never adequately trained on the technology, though trust nearly doubles among nurses who had a say in selecting the tools.
Leica Biosystems received FDA clearance for Aperio iQC DX, the first standalone AI quality-control tool for clinical digital pathology, which caught up to 24% more slide artifacts than histotechnicians in a Heidelberg University study.
Pfizer signed a license agreement with AI biologics startup Chai Discovery on June 4, 2026, gaining access to Chai-3, a model the company says doubled the success rate of therapeutic antibody design over its predecessor.
Clair Health raised $11.6 million led by Khosla Ventures to build a wrist wearable that uses machine learning to infer estrogen, progesterone, LH and FSH levels without blood tests, launching in November.
A Nature Medicine study found OpenAI's ChatGPT Health under-triaged more than half of emergency-care cases and showed inverted suicide-risk alerts, testing the tool across 960 clinical interactions.